| Foreword | |
| List of Contributors | |
| Equipment for the electrophysiology laboratory: possibilities and limitations | p. 3 |
| Vasovagal syncope: clinical presentation, classification and management | p. 15 |
| Classification of antiarrhythmic drugs in relation to mechanisms of arrhythmias | p. 23 |
| Electrophysiological characteristics in arrhythmogenic right ventricular dysplasia and dilated cardiomyopathies | p. 31 |
| Classification of death in patients under antiarrhythmic treatment | p. 41 |
| Heart rate variability. Methodology and physiological basis | p. 49 |
| Heart rate variability and QT interval: their relationships with the cardiac frequency | p. 63 |
| Role of dynamic QT interval in Holter tapes to stratify risk in postmyocardial infarction patients | p. 73 |
| Heart rate variability in patients with angina pectoris | p. 79 |
| Time and frequency domain analysis of heart rate variability after myocardial infarction | p. 83 |
| Signal averaged ECG. Technical principles, possibilities and limitations | p. 93 |
| Optimizing the predictive value of the signal-averaged ECG for serious arrhythmic events in the post-infarction period | p. 117 |
| Signal-averaged analysis of the P wave: possible applications in different settings | p. 125 |
| Late potentials during acute myocardial ischaemia | p. 134 |
| Radiofrequency catheter ablation in the treatment of supraventricular tachycardias | p. 137 |
| Anatomical versus electrophysiological approaches for ablation of the slow pathway in patients with AV nodal reentrant tachycardia | p. 145 |
| Cardiac pacing in Europe in 1992: a new survey | p. 157 |
| The myocardium-electrode interface at the cellular level | p. 169 |
| The myocardium-electrode interface at the macro level | p. 189 |
| Unipolar versus bipolar leads | p. 203 |
| Single lead VDD pacing: an update | p. 209 |
| Substantial improvement of screw-in electrodes | p. 221 |
| Physiological cardiac pacing: an individual objective | p. 227 |
| Pacemaker syndrome during atrial-based pacing | p. 251 |
| Dual chamber pacemaker therapy in cardiomyopathy | p. 269 |
| DDD rate-responsive pacing: state of the art | p. 281 |
| Heart rate response based on changes in central venous oxygen saturation, minute ventilation and body activity | p. 289 |
| DDDR and atrial arrhythmia | p. 303 |
| Holter and pacemaker diagnostics | p. 309 |
| Clinical relevance of histograms in the follow-up of DDDR pacemakers | p. 325 |
| Holter and telemetry in pacemakers and ICDs: new developments | p. 333 |
| Automatic measure of the interface capacitor and the total cardiac impedance | p. 347 |
| Critical analysis of the different algorithms designed to protect the paced patient against atrial tachyarrhythmias in dual chamber pacing | p. 355 |
| Mode switching in DDDR pacing | p. 363 |
| Indication for ICD implantation and selection of patients: present and future | p. 373 |
| The optimum tilt for defibrillation | p. 381 |
| Cerebrovasomotor reactivity predicts tolerance to tiered therapy with implantable cardioverter-defibrillators | p. 387 |
| Clinical utility of telemetered electrograms in pacemakers and ICDs | p. 399 |
| High patient acceptance for implantable cardioverter/defibrillator (ICD): quality of life and patient acceptance | p. 411 |
| Cardiac pacing and electrophysiology: how much technology do we need? | p. 419 |
| Medical technology assessment and reimbursement policy of implantable devices in Belgium: possibilities and limitations for the future | p. 423 |
| Socioeconomic aspects of implantable devices: can we afford new technology? | p. 431 |
| Index | p. 439 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
